molecular formula BaH2O4S B147921 Barium sulfate CAS No. 7727-43-7

Barium sulfate

Cat. No.: B147921
CAS No.: 7727-43-7
M. Wt: 235.41 g/mol
InChI Key: XUBKPYAWPSXPDZ-UHFFFAOYSA-N
Attention: For research use only. Not for human or veterinary use.
In Stock
  • Click on QUICK INQUIRY to receive a quote from our team of experts.
  • With the quality product at a COMPETITIVE price, you can focus more on your research.

Description

Barium sulfate is an inorganic compound with the chemical formula BaSO₄. It is a white crystalline solid that is odorless and insoluble in water. This compound occurs naturally as the mineral barite, which is the primary commercial source of barium and its derivatives . This compound is known for its high density and opacity, making it useful in various industrial and medical applications .

Synthetic Routes and Reaction Conditions:

  • Using Barium Chloride and Sulfuric Acid:

      Reaction: BaCl₂ (aqueous) + H₂SO₄ (aqueous) → BaSO₄ (solid) + 2HCl (aqueous)

      Procedure: Dissolve barium chloride in distilled water. Slowly add dilute sulfuric acid while stirring continuously. A white precipitate of this compound forms.

  • Using Barium Sulfide and Sodium Sulfate:

      Reaction: BaS (aqueous) + Na₂SO₄ (aqueous) → BaSO₄ (solid) + Na₂S (aqueous)

      Procedure: Dissolve barium sulfide in distilled water. Add sodium sulfate solution to it. A white precipitate of this compound forms.

Industrial Production Methods:

    Direct Precipitation: This method involves the interaction of barium ions and sulfate ions in a liquid environment.

Types of Reactions:

    Precipitation Reaction: this compound is formed as a precipitate when barium ions react with sulfate ions in an aqueous solution.

Common Reagents and Conditions:

Major Products:

Mechanism of Action

Target of Action

Barium sulfate is primarily used as a radiographic contrast agent for X-ray imaging and other diagnostic procedures . Its primary targets are the structures within the gastrointestinal (GI) tract .

Mode of Action

This compound works by increasing the absorption of X-rays as they pass through the body . Due to its high atomic number, barium is opaque to X-rays, which allows for the clear visualization of structures where this compound is localized . This compound is ingested or administered rectally and combined with granules of effervescent bicarbonate to enhance distension of the GI tract, allowing for enhanced visualization .

Biochemical Pathways

It remains in the GI tract without being absorbed into the bloodstream . It’s worth noting that barium ions can interfere with potassium channels in the body, affecting muscle and nerve function .

Pharmacokinetics

This compound exhibits unique pharmacokinetic properties due to its low water solubility and high level of clearance from the body . After administration, it is excreted from the body through the rectum .

Result of Action

The primary result of this compound’s action is the clear visualization of the GI tract during X-ray imaging . It allows healthcare professionals to diagnose and monitor various conditions within the GI tract .

Action Environment

The action of this compound can be influenced by environmental factors. For instance, the presence of other elements in the GI tract can affect the distribution and excretion of this compound . Additionally, the compound’s action may be influenced by the patient’s hydration status, as adequate hydration can help avoid obstruction or impaction following a this compound procedure .

Biochemical Analysis

Biochemical Properties

Barium Sulfate does not directly participate in biochemical reactions. It is primarily used in medical procedures and industrial applications due to its physical properties . It can enhance the fluorescence properties of organic dyes, making it a valuable tool in food safety and quality control .

Cellular Effects

Its primary use in the biological context is as a contrast agent in medical imaging, where it helps visualize certain structures or areas in the body .

Molecular Mechanism

The molecular mechanism of this compound primarily involves its interaction with X-rays during medical imaging. As a heavy metal compound, this compound absorbs X-rays and appears white on an X-ray film, helping to highlight the gastrointestinal tract .

Temporal Effects in Laboratory Settings

In laboratory settings, this compound is stable and does not degrade over time . It does not have any long-term effects on cellular function observed in in vitro or in vivo studies .

Dosage Effects in Animal Models

The effects of this compound in animal models are primarily related to its use as a contrast agent in medical imaging. The compound is generally considered safe at the dosages used for this purpose .

Metabolic Pathways

This compound is not involved in any known metabolic pathways. It is not metabolized by the body and is excreted unchanged .

Transport and Distribution

After oral administration, this compound is transported through the digestive tract. It is not absorbed into the body but is eliminated unchanged in the feces .

Subcellular Localization

This compound does not enter cells and therefore does not have a subcellular localization. It remains in the gastrointestinal tract after administration and is excreted unchanged .

Comparison with Similar Compounds

    Calcium Sulfate (CaSO₄): Like barium sulfate, calcium sulfate is also used in medical imaging but has different sol

Properties

Barium sulfate is a heavy metal with a high atomic number (Z=56) and a K shell binding energy (K-edge of 37.4 keV) very close to that of most diagnostic x-ray beams. Due to these characteristics, barium is an ideal medium for the absorption of x-rays. Barium sulfate is essentially not absorbed from the GI tract nor metabolized in the body. Barium sulfate is used to fill the gastrointestinal tract lumen or to coat the mucosal surface and is administered orally, rectally, or instilled into an enterostomy tube or catheter,. Barium sulfate enhances delineation of the GI tract. The barium suspension covers the mucosal surface of the GI tract, allowing its shape, distensibility, motion, integrity, continuity, location within the torso, relationship to other organs to be closely examined. Various abnormalities, such as benign or malignant tumors, ulcers, strictures, diverticula, inflammation or infection, altered motility, displacement and other pathology can thereby be identified,. At lower concentrations (higher dilution), barium enhances the conspicuity of the GI tract to differentiate the GI tract from various abdominal organs in computed tomography examinations (CT scans) of the abdomen. Improved delineation of the gastrointestinal tract lumen and mucosa may be reached by contrast provided by gas (by the addition of bicarbonate or gas-filled balloons) in addition to the barium. This is known as a _double-contrast procedure_. Osmotically active agents (for example, sorbitol) are also used to induce fluid accumulation and distension of the GI system to enhance visualization.

CAS No.

7727-43-7

Molecular Formula

BaH2O4S

Molecular Weight

235.41 g/mol

IUPAC Name

barium(2+);sulfate

InChI

InChI=1S/Ba.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)

InChI Key

XUBKPYAWPSXPDZ-UHFFFAOYSA-N

impurities

Natural impurities are ferric oxide, silicon dioxide, and strontium sulfate.

SMILES

[O-]S(=O)(=O)[O-].[Ba+2]

Canonical SMILES

OS(=O)(=O)O.[Ba]

boiling_point

2912 °F at 760 mmHg (Decomposes) (NIOSH, 2024)
decomposes
2912 °F (decomposes)
2912 °F (Decomposes)

Color/Form

Fine, heavy powder or polymorphous crystals
White, orthorhombic crystals
White or yellowish powder
Opaque powde

density

4.25 to 4.5 (NIOSH, 2024)
4.49 g/cu cm
4.5 g/cm³
4.25-4.5

melting_point

2876 °F (NIOSH, 2024)
1580 °C
2876 °F

7727-43-7
13462-86-7

physical_description

Barium sulfate appears as white or yellowish odorless powder or small crystals. Mp: 1580 °C (with decomposition). Density: 4.25 -4.5 g cm-3. Insoluble in water, dilute acids, alcohol. Soluble in hot concentrated sulfuric acid. Used as a weighting mud in oil-drilling, in paints, paper coatings, linoleum, textiles, rubber. Administered internally ("barium cocktail") as a radio-opaque diagnostic aid.
Pellets or Large Crystals;  Dry Powder;  NKRA;  Water or Solvent Wet Solid;  Other Solid;  Dry Powder, Liquid;  Liquid, Other Solid;  Liquid
White or yellowish, odorless powder;  [NIOSH] Insoluble in water;  [HSDB]
ODOURLESS TASTELESS WHITE OR YELLOWISH CRYSTALS OR POWDER.
White or yellowish, odorless powder.

Pictograms

Health Hazard

solubility

0.0002 % at 64 °F (NIOSH, 2024)
Very slightly soluble in cold water
SOLUBILITY IN WATER INCREASES CONSIDERABLY IN PRESENCE OF CHLORIDE & OTHER ANIONS
0.00031 g/100 g water at 20 °C;  insol in ethanol
Soluble in hot concentrated sulfuric acid;  practically insoluble in dilute acids and alcohol
Practically insoluble in organic solvents;  very slightly soluble in alkalis and in solution of many salts
Solubility in water: none
(64 °F): 0.0002%

Synonyms

Barite
Baritop
Barium Sulfate
Barium Sulfate (2:1)
E Z CAT
E-Z-CAT
EZCAT
Micropaque Oral
Sulfate, Barium

vapor_pressure

0 mmHg (approx) (NIOSH, 2024)
0 mmHg (approx)

Origin of Product

United States

Synthesis routes and methods I

Procedure details

Aqueous solutions of barium acetate (0.02 mol/1) and sodium sulfate (0.02mol/1) were prepared by dissolving 11.043 gm of barium acetate (special reagent grade) and 2.926 gm of sodium sulfate (special reagent grade) into 2,000 gm of ion-exchanged water. The two solutions were heated at 85° C. and mixed together. The mixture was adjusted to pH 3.0 by an addition of 5.3 cc of concentrated hydrochloric acid, followed by the reaction in the same manner as in Example 1 to obtain 6.53 gm of barium sulfate powder.
Quantity
11.043 g
Type
reactant
Reaction Step One
Quantity
2.926 g
Type
reactant
Reaction Step One
[Compound]
Name
ion-exchanged
Quantity
0 (± 1) mol
Type
reactant
Reaction Step One
Name
Quantity
0 (± 1) mol
Type
solvent
Reaction Step One
Quantity
5.3 mL
Type
reactant
Reaction Step Two
Name
barium acetate
Name
sodium sulfate
Name
barium sulfate

Synthesis routes and methods II

Procedure details

Aqueous solutions of barium acetate (0.02 mol/1) and sodium sulfate (0.02 mol/1) were prepared by dissolving 11.043 gm of barium acetate (special reagent grade) and 2.926 gm of sodium sulfate (special reagent grade) each into 2,000 gm of ion-exchanged water. Each solution was heated at 85° C. Then, 6.53 gm of barium sulfate powder was obtained in the same manner as in Example 1.
Quantity
11.043 g
Type
reactant
Reaction Step One
Quantity
2.926 g
Type
reactant
Reaction Step One
[Compound]
Name
ion-exchanged
Quantity
0 (± 1) mol
Type
reactant
Reaction Step One
Name
Quantity
0 (± 1) mol
Type
solvent
Reaction Step One
Name
barium acetate
Name
sodium sulfate
Name
barium sulfate

Synthesis routes and methods III

Procedure details

Aqueous solutions of barium chloride (0.1 mol/1) and sulfuric acid (0.1 mol/1) were prepared by dissolving 24.675 gm of barium chloride (special reagent grade) and 10.100 gm of sulfuric acid (special reagent grade) into 1,000 gm of ion-exchanged water. The two solutions were heated at 30° C., followed by the reaction in the same manner as in Example 1 at pH 5.8 to obtain 19.5 gm of barium sulfate powder.
Quantity
24.675 g
Type
reactant
Reaction Step One
Quantity
10.1 g
Type
reactant
Reaction Step One
[Compound]
Name
ion-exchanged
Quantity
0 (± 1) mol
Type
reactant
Reaction Step One
Name
Quantity
0 (± 1) mol
Type
solvent
Reaction Step One
Name
barium chloride
Name
sulfuric acid
Name
barium sulfate

Synthesis routes and methods IV

Procedure details

Aqueous solutions of barium chloride (0.008 mol/1) and sulfuric acid (0.005 mol/1) were prepared by dissolving 1.974 gm of barium chloride (special reagent grade) and 0.505 gm of sulfuric acid (special reagent grade) into 1,000 gm of ion-exchanged water. Each solution was heated at 70° C. The barium chloride solution was added dropwise over a period of 10 minutes to the sulfuric acid solution, while the latter was stirred at 1,000 rpm by a U-shaped blade. After the addition, the mixture was stirred for a further 3 minutes to complete the reaction. The mixture was kept at pH 3.5 during the reaction. After cooling to the room temperature, the reaction mixture was filtered through a 5C filter paper, washed with water, and dried at 105° C. for 2 hours to obtain 1.12 gm of barium sulfate powder.
Quantity
1.974 g
Type
reactant
Reaction Step One
Quantity
0.505 g
Type
reactant
Reaction Step One
[Compound]
Name
ion-exchanged
Quantity
0 (± 1) mol
Type
reactant
Reaction Step One
Name
Quantity
0 (± 1) mol
Type
solvent
Reaction Step One
Quantity
0 (± 1) mol
Type
reactant
Reaction Step Two
Quantity
0 (± 1) mol
Type
reactant
Reaction Step Two
Name
barium chloride
Name
sulfuric acid
Name
barium sulfate

Retrosynthesis Analysis

AI-Powered Synthesis Planning: Our tool employs the Template_relevance Pistachio, Template_relevance Bkms_metabolic, Template_relevance Pistachio_ringbreaker, Template_relevance Reaxys, Template_relevance Reaxys_biocatalysis model, leveraging a vast database of chemical reactions to predict feasible synthetic routes.

One-Step Synthesis Focus: Specifically designed for one-step synthesis, it provides concise and direct routes for your target compounds, streamlining the synthesis process.

Accurate Predictions: Utilizing the extensive PISTACHIO, BKMS_METABOLIC, PISTACHIO_RINGBREAKER, REAXYS, REAXYS_BIOCATALYSIS database, our tool offers high-accuracy predictions, reflecting the latest in chemical research and data.

Strategy Settings

Precursor scoring Relevance Heuristic
Min. plausibility 0.01
Model Template_relevance
Template Set Pistachio/Bkms_metabolic/Pistachio_ringbreaker/Reaxys/Reaxys_biocatalysis
Top-N result to add to graph 6

Feasible Synthetic Routes

Reactant of Route 1
Barium sulfate
Reactant of Route 2
Barium sulfate
Reactant of Route 3
Barium sulfate
Reactant of Route 4
Barium sulfate
Reactant of Route 5
Barium sulfate
Reactant of Route 6
Barium sulfate
Customer
Q & A

Q1: What is the molecular formula and weight of barium sulfate?

A1: this compound has the molecular formula BaSO4 and a molecular weight of 233.38 g/mol.

Q2: What are some key properties of this compound?

A2: this compound is an inorganic compound characterized by its high density, white color, and insolubility in water. It is chemically inert and thermally stable, decomposing at temperatures above 1600°C. These properties make it suitable for various applications.

Q3: How is this compound used in medical imaging?

A3: this compound is widely used as a radiopaque contrast agent in medical imaging, particularly for visualizing the gastrointestinal tract. Due to its insolubility and high atomic number, it absorbs X-rays efficiently, allowing for clear visualization of the digestive system during procedures like barium swallows and barium enemas [, ].

Q4: Are there any concerns regarding the gluten content of this compound suspensions used in medical procedures for patients with Celiac disease?

A4: Yes, determining the gluten content of commercially available this compound suspensions can be challenging. A study revealed that a significant proportion of hospitals and imaging centers were unaware of the gluten content in the contrast media they used []. Clinicians need to ensure gluten-free this compound suspensions are used for patients with Celiac disease or those following a gluten-free diet.

Q5: Can this compound be used for imaging modalities other than X-ray?

A5: Research suggests this compound can be combined with near-infrared-II (NIR-II) absorbing pigments to create a dual-modality contrast agent for both X-ray and photoacoustic imaging (PAI) []. This could allow for complementary imaging information from a single contrast administration.

Q6: Are there any risks associated with the use of this compound in medical imaging?

A6: While generally considered safe, there have been isolated reports of complications related to this compound use. In one instance, a hemodialysis catheter fracture was attributed to the accumulation of this compound particles within the catheter material []. This emphasizes the importance of careful formulation and quality control in the manufacturing of medical-grade this compound.

Q7: Can this compound be used as a filler in polymer composites?

A7: Yes, this compound can function as a filler in polymer composites. For example, incorporating this compound into polypropylene/polystyrene blends can modify the blend's microstructure and dynamic mechanical properties []. The presence of specific modifiers, such as maleic anhydride-grafted polypropylene, can influence the filler's distribution within the polymer matrix, further affecting the composite's properties.

Q8: How does this compound contribute to radiation shielding?

A8: this compound's high atomic number makes it effective for attenuating X-rays. Studies have explored its use in radiation-shielding materials. One study investigated incorporating this compound into bricks, showing promising X-ray shielding properties with increasing this compound content []. Another study developed X-ray-shielding films using this compound nanoparticles embedded in a polyethylene terephthalate (PET) matrix, demonstrating potential as an alternative to lead-based shielding materials [].

Q9: Can this compound be used to create colored pigments?

A9: Yes, this compound can be used as a base material for producing pigments. One study describes a method of depositing ferric oxide onto this compound particles, creating a novel pigment with enhanced optical and functional properties for architectural and industrial coatings [].

Q10: What are the environmental concerns associated with this compound?

A10: While this compound itself is considered relatively inert and non-toxic, its production and disposal can have environmental impacts. The mining of barite, the primary source of this compound, can lead to habitat destruction and pollution. The responsible management of this compound waste, including recycling and proper disposal practices, is crucial for minimizing environmental harm [].

Q11: How is this compound typically synthesized?

A11: this compound is commonly synthesized through precipitation reactions involving soluble barium salts, such as barium chloride, and sulfate-containing solutions, like sulfuric acid or sodium sulfate [, ]. Controlling reaction parameters like concentration, temperature, and the presence of additives can influence the particle size, morphology, and purity of the synthesized this compound.

Q12: Are there methods for analyzing the sulfur isotope ratio in this compound derived from historical artifacts containing vermilion (mercuric sulfide)?

A12: Yes, a method for analyzing the sulfur isotope ratio in this compound prepared from vermilion has been developed to prevent mercury contamination []. This method involves dissolving mercuric sulfide in reverse aqua regia, oxidizing sulfur ions to sulfate ions with bromine, and then directly adding barium chloride to precipitate this compound without the need for ion-exchange resins. This technique ensures accurate sulfur isotope analysis while minimizing mercury contamination.

Disclaimer and Information on In-Vitro Research Products

Please be aware that all articles and product information presented on BenchChem are intended solely for informational purposes. The products available for purchase on BenchChem are specifically designed for in-vitro studies, which are conducted outside of living organisms. In-vitro studies, derived from the Latin term "in glass," involve experiments performed in controlled laboratory settings using cells or tissues. It is important to note that these products are not categorized as medicines or drugs, and they have not received approval from the FDA for the prevention, treatment, or cure of any medical condition, ailment, or disease. We must emphasize that any form of bodily introduction of these products into humans or animals is strictly prohibited by law. It is essential to adhere to these guidelines to ensure compliance with legal and ethical standards in research and experimentation.